The real difference is not potency. It is what you go through to get it.

CHOOSING BETWEEN THE TWO

PRP is concentrated platelets from a blood draw. BMAC is concentrated marrow from the iliac crest (the top rim of the pelvis). It adds a mixed group of cells, plus a harvest site that aches for days. PRP comes first for tendons, where it has the evidence. It also comes first for earlier-stage joints, where results run close. BMAC pulls ahead as a knee gets worse, and in osteonecrosis.

Both treatments take tissue from you, concentrate it, and put it back the same day. That is where the likeness ends. They differ in what is delivered, how it is collected, and what it costs. And — the point most often skipped — they differ in infection risk, and so in whether antibiotics belong anywhere near them.

How are PRP and BMAC collected?

PRP comes from a blood draw from a vein. A tube of blood, a centrifuge, a concentrate of platelets, and back into the target under image guidance. It takes about an hour in total, and the draw itself is routine.

BMAC comes from your iliac crest. Marrow is drawn out through a hollow needle (a trocar) under local anesthetic, then concentrated and injected. It is a truly different level of procedure. The harvest site usually aches for several days — sometimes more than the joint being treated.

What is actually in PRP and BMAC?

PRP delivers concentrated platelets and the growth factors stored in them (in their alpha granules): PDGF, TGF-β, VEGF, EGF, IGF-1. It holds no cells that could become tissue — signal only.

BMAC delivers a mixed group of nucleated cells, plus platelets and signaling molecules. The mesenchymal stromal fraction that gives it its fame is a small minority, well under one percent of nucleated cells. That is more than PRP contains. It is also far less than the phrase “stem cell treatment” implies.

Infection risk, and the antibiotic decision

Pooled randomized data across six trials and 860 patients puts the complication rate for BMAC at about 42% against 41% for comparator injections — no significant difference. Joint fluid buildup (effusion) was the most common event. Marrow is not more likely to cause a problem. What differs is how serious it is. An infection seeded at or near bone is a more serious problem than a soft-tissue one. That is what changes the technique and the antibiotic decision.

This is the difference that changes clinical practice, and it should be stated plainly.

BMAC carries a more serious infection risk, not a more frequent one. Harvesting marrow means entering bone. An infection seeded at or near bone is a far more serious problem than a soft-tissue infection — longer treatment, worse outcomes, sometimes surgery. That higher risk is mitigated by prophylactic antibiotics, and they are used for this procedure.

PRP carries a low infection risk, and antibiotics do not help it. A blood draw and a soft-tissue injection done under sterile technique do not reach the point where preventive antibiotics change outcomes. Giving them anyway adds stomach and gut side effects, allergy risk and resistance pressure. It takes nothing away from the risk. So we do not give them.

Say a clinic consents you for both procedures with one risk talk and one antibiotic policy. Then it has not told them apart. That is worth noticing before you agree to either.

Does a BMAC bone marrow harvest hurt more than PRP?

PRP: a blood draw, a local anesthetic, an injection, and a flare lasting a few days at the treated site.

BMAC: the same at the treated site, plus a harvest. Local anesthesia numbs the skin and the bone’s outer lining (periosteum) well. But the feeling of marrow being drawn out is distinct, and briefly unpleasant for most people. The crest is sore to lie on for several days. People should be told this plainly, not find it out the hard way.

Is BMAC better than PRP for knee arthritis?

Fewer direct comparisons exist than either side of the argument implies. In knee osteoarthritis the picture has shifted. Earlier head-to-head trials generally found no statistically significant difference in pain and function at twelve months. A newer single-center trial of 175 patients across Kellgren–Lawrence grades II to IV (the X-ray arthritis scale) found otherwise: BMAC produced the greatest quality-of-life gains. It came out ahead of both PRP and hyaluronic acid. The difference was most marked in physical health and mobility.

The two findings fit together through disease stage. Neither one is wrong. The two treatments run close in earlier joints, and marrow pulls ahead as the joint gets worse. That is also where the four-year BMAC data in grade III and IV knees was earned. So take an earlier-stage joint, where results are similar and BMAC is the harder procedure that costs several times more. That is a real case for starting with PRP. For a joint further along, it stops being one.

For tendinopathy, there is essentially no comparison evidence favoring BMAC, and PRP has a large body of research. For osteonecrosis (bone death) the position flips. Marrow-based treatment has a better case there than anywhere else on this site.

A side-by-side summary

• Source. PRP: venous blood. BMAC: iliac crest marrow.
• Delivered. PRP: platelets and growth factors. BMAC: mixed cells plus signal.
• Infection risk. PRP: low. BMAC: higher, and bone-adjacent.
• Antibiotic prophylaxis. PRP: no, it does not help. BMAC: yes, it does.
• Recovery from the procedure itself. PRP: a flare. BMAC: a flare plus a sore harvest site.
• Cost. PRP lower; BMAC several times higher.
• Evidence in tendinopathy. PRP substantially better supported.
• Evidence in knee arthritis. Comparable at a year.
• Evidence in osteonecrosis. BMAC better supported.

When should you choose BMAC over PRP?

PRP first for earlier-stage joints, because it performs about as well there at lower cost and with far less to endure. Marrow where the joint is further along. Marrow where PRP has produced a partial response worth building on, or where the bone under the cartilage (subchondral bone) is part of the picture. And marrow where the use is specific to it — osteonecrosis of the femoral head has no plasma equivalent.

Stepping up on evidence is a better order than starting with the bigger procedure because it sounds more impressive. If someone recommends BMAC as a first move for a tennis elbow, ask them why.

What neither one does

Neither regrows cartilage in an arthritic joint. Neither repairs a large tendon tear where the tendon has pulled back. Neither takes the place of a joint replacement where the structure is the problem — though both are used in end-stage disease to buy time and cut medication burden. And neither removes the need for the loading program afterward. Any comparison that leaves those out is selling rather than explaining.

Why “more cells” is not obviously better

The gut-level case for BMAC is that it delivers cells and PRP does not, so it must do more. That assumes the cells take hold (engraft) and become tissue. The current understanding is that they largely do not.

What the delivered cells appear to do is signal. They release growth factors, cytokines and extracellular vesicles that modulate inflammation and influence the cells already living in the tissue. Then they disappear within days. If signaling is the mechanism, then a prep rich in growth factors competes on the same terms. That is exactly what the head-to-head results suggest.

That does not make cell content irrelevant. It does mean the cell count stands in for signaling power. It is not a measure of how much new tissue you are buying. And it explains why a several-fold price difference has not turned into a several-fold outcome difference in any trial so far.

Practical differences on the day

• Time. PRP is easily done in an hour. BMAC takes longer, with the harvest, processing and positioning.
• Positioning. The harvest requires lying face down or on your side for a while. That matters if that is hard for you.
• Driving home. Most people drive after PRP. After a marrow harvest, particularly with any sedation, plan for someone to take you.
• Time off. PRP rarely needs any. BMAC often calls for a day, and longer if your work involves lifting or long sitting on the harvest side.
• Repeatability. A second PRP injection is a minor task. A second marrow harvest is not. That imbalance should factor into a plan that may need more than one round.

Choosing between the two

Is BMAC stronger than PRP?

Not in a way studies have shown, in knee arthritis at a year. It is more invasive and costs more. What BMAC actually is.

Why antibiotics for one and not the other?

Entering bone justifies preventive antibiotics. A soft-tissue injection does not, and antibiotics do not reduce PRP’s risk. Risks and side effects.

Is BMAC the same as stem cell therapy?

It is what most clinics mean by it, though the stem cell fraction is very small. What that phrase actually means.

Which should I start with?

PRP, for most uses. Step up on evidence, not on marketing. Candidacy.

Can PRP or BMAC regrow knee cartilage?

No. Neither PRP nor BMAC regrows cartilage in an arthritic joint. Neither repairs a large tendon tear where the tendon has pulled back. In end-stage disease, both are used to buy time and cut medication burden. They are not used to replace a joint where the structure is the problem. Neither removes the need for the loading program afterward. A comparison that leaves this out is selling rather than explaining.

Do the stem cells in BMAC grow new tissue?

The current understanding is that they largely do not. The delivered cells appear to signal. They release growth factors, cytokines and extracellular vesicles that calm inflammation and influence the cells already in the tissue. Then they disappear within days. The mesenchymal fraction is well under one percent of the nucleated cells. So the cell count is a stand-in for signaling, not a measure of new tissue.

What are the downsides of BMAC compared with PRP?

BMAC adds a marrow harvest from the iliac crest. The harvest site is sore to lie on for several days, the procedure takes longer, and you should plan for someone to drive you home. It often warrants a day off work. It costs several times more, a second harvest is a bigger undertaking than a second PRP injection, and its infection risk is more serious, so prophylactic antibiotics are used.

How long does a PRP injection take, and can I drive home?

PRP takes about an hour: a blood draw, a centrifuge and an image-guided injection. Most people drive themselves home and rarely need time off. Expect a flare at the treated site lasting a few days. BMAC takes longer because of the harvest, processing and positioning, and after a marrow harvest, particularly with any sedation, plan for someone else to drive.

Related reading

• Bone marrow aspirate concentrate
• PRP compared with stem cell treatments
• Risks and side effects
• PRP for knee osteoarthritis